Cannabis News Box

GW Pharmaceuticals gains approval from European Commission for EPIDYOLEX®

GW Pharmaceuticals gains approval from European Commission for EPIDYOLEX®

Bethan Rose Jenkins, Cannabis News Writer/Editorial

October 2, 2019

British drugs company GW Pharmaceuticals celebrated approval for its cannabinoid-based epilepsy medicine EPIDYOLEX® back in June 2018 in the United States.  Now, EPIDYOLEX has also gained approval from the European Commission, thus allowing the epilepsy treatment to be prescribed to diagnosed pat...

Will Epidiolex be the first cannabis-based drug to be approved as an epilepsy treatment?

Will Epidiolex be the first cannabis-based drug to be approved as an epilepsy treatment?

Bethan Rose Jenkins, Cannabis News Writer/Editorial

May 3, 2018

A cannabis-based medication for epilepsy could be the first to gain approval by the Food and Drug Administration (FDA). Created by British company GW Pharmaceuticals, cannabis-based epilepsy treatment Epidiolex will undergo FDA review this June. Things are looking hopeful, with a panel of 13 advisors...

Clinical trial shows cannabis extract reduces seizures in kids with rare disorder

Clinical trial shows cannabis extract reduces seizures in kids with rare disorder

May 25, 2017

Patients with a rare and debilitating form of epilepsy called Dravet syndrome have experienced a significant reduction in seizures after being treated with cannabis. In some cases, patients' seizures were eliminated completely. The study, which was published May 24 in the New England Journal of Medici...

Dravet syndrome